What's coming to Contemporary OB/GYN® this week?
Investigators found that opioid use during pregnancy increases the relative risk of neonatal opioid withdrawal syndrome in newborns.
Researchers have found that maternal antenatal corticosteroid treatment can lead to increased risk of psychological developmental and neurosensory disorders in children.
This month's issue focuses on barriers and access to care, from emergency contraception to reproductive care in adolescents with disabilities. Stay up to date on the latest guidelines and recommendations for monkeypox in pregnancy. Plus, get a recap of what you missed at ASCO 2022.
This month's guest editorial features perspectives from Drs. Frances Grimstad, Elizabeth Bosky, and Jessica Kremen of the landscape of inclusion in health care.
Consider the needs of marginalized patients to promote equity.
Nearly half (45%) of all pregnancies in the United States from 2015 to 2019 were unintended. Unfortunately, patients are likely to receive inaccurate information about emergency contraceptive pills from retail pharmacies, and significant gaps exist in training and knowledge of emergency contraception among ob-gyn and family medicine residents.
Check back soon for additional updates.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More